Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2008-3-17
pubmed:abstractText
Methylglyoxal (MG) is generated through the Embden-Meyerhof and polyol pathways, and it rapidly reacts with proteins to form advanced glycation end products (AGE) such as N(epsilon)-(carboxyethyl)lysine (CEL). In the present study, polyclonal and monoclonal antibodies specific for CEL were prepared to estimate CEL content in aldehydes-modified proteins and the pathological localization in human kidneys. Polyclonal CEL-specific antibody was prepared by removing cross-reactive antibodies against N(epsilon)-(carboxymethyl) lysine (CML), one of the major AGE structures, using CML-conjugated affinity chromatography. Monoclonal CEL-specific antibody (CEL-SP) was obtained by immunization with CEL-bovine serum albumin, followed by successive screening according to CEL-RNase-positive but CML-RNase-negative criteria. A non-competitive ELISA showed that both the polyclonal and monoclonal CEL-specific antibodies significantly reacted with CEL-proteins but not with CML-proteins. A competitive ELISA also demonstrated that CEL-SP does not show cross-reactivity against CEL analogues such as CML, carboxymethylarginine (CMA) and S-carboxymethylcysteine (CMC), thus indicating that antibody is able to recognize the difference of one methyl group between carboxymethyl group and carboxyethyl group. Furthermore, CEL-SP significantly reacted with human serum albumin modified with MG but not with glyoxal or 3-deoxyglucosone, and its reactivity was highly correlated with the CEL content, which was determined by high performance liquid chromatography. Immunohistochemical studies using CEL-SP provided evidence that CEL-modified proteins accumulate in distal tubular epithelial cells of the diabetic rat. These results demonstrate that a specific antibody against CEL can be a powerful tool for detecting CEL both in vitro and in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1759
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
332
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-20
pubmed:meshHeading
pubmed-meshheading:18242632-Aldehydes, pubmed-meshheading:18242632-Animals, pubmed-meshheading:18242632-Antibodies, Monoclonal, pubmed-meshheading:18242632-Antibody Specificity, pubmed-meshheading:18242632-Antigen-Antibody Reactions, pubmed-meshheading:18242632-Cattle, pubmed-meshheading:18242632-Chromatography, High Pressure Liquid, pubmed-meshheading:18242632-Diabetes Mellitus, Experimental, pubmed-meshheading:18242632-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18242632-Humans, pubmed-meshheading:18242632-Immunohistochemistry, pubmed-meshheading:18242632-Kidney, pubmed-meshheading:18242632-Lysine, pubmed-meshheading:18242632-Male, pubmed-meshheading:18242632-Pyruvaldehyde, pubmed-meshheading:18242632-Rats, pubmed-meshheading:18242632-Rats, Wistar, pubmed-meshheading:18242632-Sensitivity and Specificity, pubmed-meshheading:18242632-Serum Albumin
pubmed:year
2008
pubmed:articleTitle
Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
pubmed:affiliation
Department of Medical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. nagai-883@umin.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't